Canaccord Starts Eton Pharmaceuticals (ETON) at Buy
Tweet
Share
E-mailGet Alerts ETON Hot Sheet
Price: $58.45 -2.42%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Canaccord analyst Gary Newman initiates coverage on Eton Pharmaceuticals (NASDAQ: ETON) with a Buy rating and a price target of $60.00.
For an analyst ratings summary and ratings history on Eton Pharmaceuticals click here. For more ratings news on Eton Pharmaceuticals click here.
Shares of Eton Pharmaceuticals closed at $38.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: We May Hit Pickaxe Very Soon
- TD Cowen on Boston Scientific (BSX): 'Shipping Confirmed With Physician Contacts', 'We view the news as a big step forward'
- Seagate board member Arumugavelu to step down at annual meeting
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
